Skip to content

A multicenter, real-world study of sequential therapy for LPD infertility with“Enhancing endometrial receptivity” as the efficacy point

A multicenter, real-world study of sequential therapy for LPD infertility with“Enhancing endometrial receptivity” as the efficacy point

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074804
Enrollment
Unknown
Registered
2023-08-16
Start date
2022-01-13
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Chinese medicine group:No
Western medicine group:No
Chinese medicine and Western medicine group:No

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) According with standard of the diagnosis of infertility with LPD. (2) Female patients aged 20-40 years. (3) Lipiodol hysterosalpingography showed patency of at least one fallopian tube. (4) Spousal semen examination is basically normal. (5) Informed consent.

Exclusion criteria

Exclusion criteria: (1) Organic pathological changes of reproductive system. (2) Hysteromyoma and pelvic inflammatory disease. (3) Other reproductive endocrine disease such as premature ovarian failure. (4) Complicated with other serious internal disease and mental disease (5) Exposure to teratogenic doses of radiation, poison and drugs and in the active phase. (6) Serious diseases of heart, brain, respiration, digestion, nerve and spirit. (7) History of alcoholism and drug dependence.

Design outcomes

Primary

MeasureTime frame
Endometrial receptivity;pregnancy rate;TCM syndrome integral;

Secondary

MeasureTime frame
Sex Hormones in the early follicular phase;Sex hormones in ovulation;Sex hormones in midluteal phase;Distribution characteristics of vaginal and uterine flora;Markers of endometrial receptivity;ovulation,;

Countries

China

Contacts

Public ContactZhou Huifang

Affiliated Hospital of Nanjing University of Chinese Medicine

zhouhuifang2011301@163.com+86 138 5185 8108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026